Autres langues Hyloris Pharmaceuticals SA

Actions

HYL

BE0974363955

Marché Fermé - Euronext Bruxelles Autres places de cotation 17:37:36 26/04/2024			Varia. 5j.	Varia. 1 janv.
11,7 ^EUR	-1,27%		-2,50%	-8,24%

14/03	Hyloris Pharmaceuticals SA fournit des prévisions de résultats pour 2024	CI
14/03	Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Degroof Petercam verhoogt koersdoel Hyloris Pharma	05/04
KBC Securities verhoogt koersdoel Hyloris	27/03
Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024	14/03
Meer omzet maar ook groter verlies voor Hyloris	14/03
Hyloris Reports Full Year Results for 2023 & Provides Business Outlook	14/03
Communication at the request of the FSMA on the transactions with Qliniq	14/03
Hyloris Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Communication at the request of the FSMA on the transactions with Qliniq	14/03
Hyloris to Report 2023 Full-Year Results on 14 March 2024	08/03
Hyloris to Report 2023 Full-Year Results on 14 March 2024	08/03
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	28/02
Hyloris lanceert Maxigesic IV in de VS	27/02
Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada	27/02
Hyloris Starts Patient Recruitment in Late-stage Trial for Proprietary Oral Rinse	15/02
Hyloris van start met Fase 3 studie	14/02
Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures	14/02
Hyloris Pharmaceuticals SA Enrolls First Patient in Phase 3 Clinical Trial for Its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures	14/02
AFT Pharmaceuticals' Licensee Launches Pain Relief Medication in US; Shares Rise 4%	07/02
AFT Pharmaceuticals’ Maxigesic IV Launches in the US	06/02
Kepler Cheuvreux verhoogt koersdoel Hyloris	31/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hyloris Pharmaceuticals SA

Actions

HYL

BE0974363955

Autres langues

Filtres